SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs Post author:Sam Post published:January 30, 2018 Post category:BioPharma Vical announced its restructuring late Tuesday. Source: BioSpace You Might Also Like Death Count Rises for Patients on Dynavax's Hep B Vaccine But Overall Rate Was Low, Says the FDA July 25, 2017 Catalent Reports Second Quarter Fiscal Year 2017 Results February 6, 2017 Bay Area Biotech Forges Multi-Year Research Deal with Genentech December 18, 2017
Death Count Rises for Patients on Dynavax's Hep B Vaccine But Overall Rate Was Low, Says the FDA July 25, 2017
